To test the potential for simultaneous inhibition of CDK4/6 and OLIG2 to produce a greater anti-tumor effect compared to either intervention alone, we treated replicate G-Smo mice with POx-Palbo plus CT-179 and then compared PK effects and efficacy versus CT-179 alone or POx-Palbo alone. Here, CDK4 is linked to neoplasm.